Kures is a pre-clinical-stage biopharmaceutical startup that develops opioid-based treatments for depressive disorder.The biopharmaceutical company is also interested in addressing other challenging indications in the psychiatry and physical pain arena using its portfolio of novel small molecules. I... Read more